new & supporting data for optimizing therapy in her2 breast cancer | dr. meisel & dr. soliman
Published 3 years ago • 816 plays • Length 1:03:44Download video MP4
Download video MP3
Similar videos
-
1:07:43
new & supporting data for optimizing therapy in her2 breast cancer | dr. mahtani & dr. schwartzberg
-
51:56
new & supporting data for optimizing therapy in her2 breast cancer | dr. kaklamani and dr. o’regan
-
51:01
new & supporting data for optimizing therapy in her2 breast cancer | dr. traina & dr. carey
-
47:29
optimizing therapy in her2 disease with dr. reshma mahtani
-
45:55
optimizing therapy in her2 disease with dr. alvaro moreno-aspitia
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
0:58
dr. soliman on investigational combination therapies in patients with breast cancer
-
1:17
comment: phase 3 study shows her2 therapy clinically meaningful for metastatic breast cancer pts
-
1:37
dr. meisel on optimizing genomic assays in early-stage hr-positive, her2-negative breast cancer
-
1:28
dr. soliman on impact of mammaprint in patients with early-stage breast cancer
-
3:43
what treatment is recommended for a newly diagnosed patient?
-
1:01:34
er breast cancer case panel discussion | 2022 best of breast conference
-
2:08
dr. gorantla on the impact of the aphinity trial in her2 breast cancer
-
0:49
dr. o’regan on prognostic value of pcr in her2 breast cancer
-
1:04
dr. meisel on emerging treatment strategies in tnbc
-
7:40
sequencing of therapy in r/r her2 mbc
-
6:28
the aphinity trial regimen efficacy & toxicity profile
-
2:49
procure: genomic signatures and adjuvant chemotherapy for breast cancer in europe